Revvity, Inc.

NYSE:RVTY

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

🩺 Medical Instruments

🔍 Research & Consulting

Location

United States

Market Cap

USD 12.22 B

Share Price

USD 103.67

Avg Daily Volume

1,289,863

Change (1 day)

1.67%

Change (1 year)

-8.10%

Change (YTD)

-7.11%

Revvity, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 30, 2025: 30.57%

Revvity, Inc. EBITDA Margin is 30.57% for the Trailing 12 Months (TTM) ending March 30, 2025, a 5.37% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Revvity, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was 29.02%, a -10.98% change year over year.
Revvity, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending April 02, 2023 was 32.60%, a 9.02% change year over year.
Revvity, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was 29.90%, a -20.40% change year over year.
Revvity, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was 37.56%, a 78.32% change year over year.